Neonates were monitored with a cerebral oximeter before, during, and after cannulation for ECMO to determine the direct effects of ligation of the right internal jugular vein and right carotid artery ...
LONDON--(BUSINESS WIRE)--LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced its Bi-Flow Extracorporeal Membrane Oxygenation (ECMO) cannula earned ...
January 13, 2010 (Miami, Florida) — Carotid artery (CA) cannulation for veno-arterial extracorporeal membrane oxygenation (ECMO) is associated with a higher risk for central nervous system (CNS) ...
Use of left atrial venoarterial cannulation during extracorporeal membrane oxygenation—a technique known as LAVA ECMO—appears to be a safe and feasible means of support for patients with cardiogenic ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window HONOLULU -- In ...
Bi-Flow is first bidirectional femoral arterial cannula validated for 29 days’ use LONDON--(BUSINESS WIRE)-- LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, ...
Bi-Flow is first bidirectional femoral arterial cannula validated for 29 days' use LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced its Bi-Flow ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback